E
ELV
ELVUnverified7 segments tracked|3 years of data|Annual (10-K)
Total Revenue
$204.5B8.0%
FY2025
Operating Segments
7Active segments
Blended Margin
3.8%Operating margin
Highest Margin
6.0%Carelon Rx
Segment Shift
Carelon Rx has grown from 0.0% to 17.6% of total revenue since FY2023, with 6.0% operating margins.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Health Benefits | $150.3B | $6.2B | 4.2% | 73.5% | +0.0% |
| Carelon Rx | $36.0B | $2.2B | 6.0% | 17.6% | +58.9% |
| Carelon Services | $18.0B | $717M | 4.0% | 8.8% | +0.0% |
| Corporate And Other | $309M | $-1.3B | -411.0% | 0.2% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free